Prenatal and Newborn Genetic Testing Market Global Trends and Forecast, 2013 - 2019 - Transparency Market Research

The Global prenatal and genetic testing market is estimated to be worth US$8.37 billion by 2019. TMR states that the market for prenatal and newborn testing was worth US$1.12 billion in 2012, and will exhibit exponential growth at 26.9% CAGR from 2013 to 2019. The report, titled “Prenatal and New-born Genetic Testing Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, is available for sale on the company website. The research report offers detailed insights into growth opportunities of major testing procedures, key regional markets for the same, and factors influencing the global market for prenatal and newborn genetic testing.Prenatal and newborn genetic testing involves the use of diagnostic or screening procedures for detecting chromosomal abnormalities in a fetus or in a newborn baby. The abnormalities include: Down syndrome, Patau Syndrome, and Edward Syndrome. Prenatal testing and diagnosis enables detection of genetic abnormalities in 8 to 10 weeks of gestation and also determines the sex of the fetus.

 

According to the report, increase in average maternal age and late pregnancies, technological advancements in diagnostic techniques, and growing awareness about detecting genetic disorders in newborns and fetuses are the major factors driving the global prenatal and newborn genetic testing market.Worldwide, the rising number of chromosomal defects among newborns and fetuses has led to increased awareness among expectant mothers, who are increasingly undergoing such screening procedures to detect genetic abnormalities at an early stage, adds the report. As per data from Northwestern Medical Faculty Foundation, a majority of pregnant women in the U.S. undergo testing or screening for birth defects such as Down syndrome, trisomy 18, and open neural tube defects.

 

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1744

 

The report segments the global prenatal and newborn genetic testing market on two fronts: technology and geography. Based on technology, the market is divided into screening tests and diagnostic tests.The study describes techniques for diagnostic tests, which include polymerase chain reaction (PCR), array comparative genomic hybridization (aCGH), and fluorescence in-situ hybridization (FISH), while screening techniques include maternal serum and noninvasive prenatal testing (NIPT).Amongst all diagnostic tests, PCR held the largest share of the market, followed by aCGH and FISH. The growth of this segment is attributed to rising genetic diseases, combined with advantages of PCR such as procedural efficiency, high accuracy and reliability, and amplification.Among the screening tests in the market, noninvasive prenatal testing (NIPT) was registered as the largest segment, with the segment projected to exhibit the highest CAGR of all segments from 2013 to 2019 – 37.6%.

 

Furthermore, based on geography, a detailed overview of the prenatal and newborn testing is included in the report. North America accounts as the largest market, due to rising popularity of NIPT, which is noninvasive and completely eliminates the risk of miscarriage associated with CVS (chorionic villus sampling) and amniocentesis.Asia Pacific registered the second highest CAGR, due to rising awareness about genetic testing, increasing incidence of genetic diseases, and overall economic development leading to higher spending for healthcare procedures.

 

Browse the full Prenatal and New-born Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at http://www.transparencymarketresearch.com/prenatal-new-born-genetic-testing.html